Lentiviral Vector Production Titer Is Not Limited in HEK293T by Induced Intracellular Innate Immunity

Most gene therapy lentiviral vector (LV) production platforms employ HEK293T cells expressing the oncogenic SV40 large T-antigen (TAg) that is thought to promote plasmid-mediated gene expression. Studies on other viral oncogenes suggest that TAg may also inhibit the intracellular autonomous innate i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Carolina B., Sumner, Rebecca P., Rodriguez-Plata, Maria T., Rasaiyaah, Jane, Milne, Richard S., Thrasher, Adrian J., Qasim, Waseem, Towers, Greg J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965512/
https://www.ncbi.nlm.nih.gov/pubmed/31970199
http://dx.doi.org/10.1016/j.omtm.2019.11.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965512/
https://www.ncbi.nlm.nih.gov/pubmed/31970199
http://dx.doi.org/10.1016/j.omtm.2019.11.021

Ejemplares similares